Photo of Philip Crawford Amrein, MD

Philip Crawford Amrein, MD


Accepting New Patients





Centers & Specialties

Cancer Center

Clinical Interests
  • Acute leukemia
  • Chronic leukemia
  • Myelodysplasia
  • Myeloproliferative neoplasms
Medical Education
  • MD, Johns Hopkins University School of Medicine
  • Residency, Waterbury Hospital Health Center
  • Fellowship, Massachusetts General Hospital
Board Certifications
  • Internal Medicine
  • Medical Oncology
  • Boston: Massachusetts General Hospital
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • MassHealth
  • Medicare
  • Medicare - ACD
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - New York
  • OSW - Rhode Island
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Railroad Medicare - ACD
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Patient Age Group

Edit Profile

Research & Publications

1) Schiffer CA,...Amrein PC,..."A double-blind, placebo-controlled trial of pegylated recombinant MGDF as an adjunct to induction and consolidation therapy to patients with acute myeloid leukemia". Blood 2000;95:2530-2535.
2) Moore JO,...Amrein PC,...."Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: CALGB study 9222". Blood 2005;105:3420-3427.
3) Attar EC,...Amrein PC. "Phase I and pharmacokinetic  study of bortezomib in combination with idarubicin and cytarabine in patients with AML".  Clinical Cancer Research 2008;14:1446-1454.
4) DeAngelo D,...Amrein PC,..."A multicenter phase II study using a dose intensified pediatric regimen in adults with untreated acute lymphocytic leukemia". Blood (ASH abstract #580) 2007.
5) Amrein PC, et al. "Dasatinib has activity in relapsed/refractory CLL/SLL". Blood (ASH abstract #3162) 2008.

Edit Profile


Hematology/Oncology BMT Program
100 Blossom Street
Boston MA, 02114-2606
Phone 1: 617-724-3456
Phone 2: 617-726-8748
Fax: 617-724-2525

Edit Profile

Back to Top